- Genome Announcement
- Open Access
A draft genome of Escherichia coli sequence type 127 strain 2009-46
- Aaron E Darling†1Email author,
- Jessica McKinnon†1,
- Paul Worden1,
- Jerran Santos1,
- Ian G Charles1,
- Piklu Roy Chowdhury1, 2 and
- Steven P Djordjevic1
© Darling et al.; licensee BioMed Central Ltd. 2014
- Received: 3 June 2014
- Accepted: 15 July 2014
- Published: 1 September 2014
Escherichia coli are a frequent cause of urinary tract infections (UTI) and are thought to have a foodborne origin. E. coli with sequence type 127 (ST127) are emerging pathogens increasingly implicated as a cause of urinary tract infections (UTI) globally. A ST127 isolate (2009-46) resistant to ampicillin and trimethoprim was recovered from the urine of a 56 year old patient with a UTI from a hospital in Sydney, Australia and was characterised here.
We sequenced the genome of Escherichia coli 2009-46 using the Illumina Nextera XT and MiSeq technologies. Assembly of the sequence data reconstructed a 5.14 Mbp genome in 89 scaffolds with an N50 of 161 kbp. The genome has extensive similarity to other sequenced uropathogenic E. coli genomes, but also has several genes that are potentially related to virulence and pathogenicity that are not present in the reference E. coli strain.
E. coli 2009-46 is a multiple antibiotic resistant, phylogroup B2 isolate recovered from a patient with a UTI. This is the first description of a drug resistant E. coli ST127 in Australia.
- Escherichia coli 2009-46
Escherichia coli infections of the urinary tract are among the most frequent infections reported in the developed world with an estimated 130-175 million cases per annum worldwide. E. coli that cause urinary tract infections (UTI) are classified as uropathogenic Escherichia coli (UPEC), a subgroup of extraintestinal pathogenic E. coli (ExPEC). ExPEC also cause a range of afflictions including meningitis, septicaemia, and pneumonia and are genotypically and phenotypically distinct from diarrhoegenic E. coli (DEC). ExPEC are thought to be acquired orally via the consumption of contaminated food and are considered to be zoonotic pathogens[3–5]. The emergence of multiple antibiotic resistance among ExPEC poses a serious health threat; antibiotics are an important treatment strategy for controlling UTI.
Multilocus sequence typing (MLST) is currently the gold standard for characterising E. coli causing UTI. No clear diagnostic markers are available for identifying E. coli causing UTI, but several sequence types (ST) including ST131, ST405, ST95, ST65, ST127, and ST10 are recognised UTI pathogens. ExPEC ST127 are described as community-acquired and highly virulent zoonotic pathogens[3, 6] but to our knowledge there are no genome sequences representing antibiotic resistant isolates of this emerging pathogen. Studies of E. coli causing UTI in Australia have focussed on characterising ST131[7, 8] and serogroup O75 isolates belonging to clonal complex 14.
Here we describe the genome sequence of E. coli ST127 isolate 2009-46, a mid-stream urinary tract isolate from a 56 year old patient from the Sydney Adventist Hospital (SAN clinic) resistant to ampicillin and trimethoprim.
The isolate was supplied on a Sensi-agar plate from the SAN laboratories in Sydney, Australia. To confirm pure culture, a loopful of the isolate was streaked onto a Luria Bertani (LB) Agar plate and incubated at 37°C for long term storage in minus 80°C as a glycerol stock. A single colony was picked from the plate and subcultured in 10 mL LB broth at 37°C overnight. To prepare the glycerol stock culture 7 mL of the overnight was used, and genomic DNA was prepared from the remaining 3 mL. Genomic DNA for sequencing was prepared using the ISOLATE II gDNA extraction kit from Bioline.
DNA was quantified using qubit flourimetry and 0.5 ng of gDNA was used as template to construct the sequencing library, using the Illumina Nextera XT library preparation protocol following the manufacturer’s instructions. However, the "PCR Clean-Up" and "Library Normalization" steps were omitted and size selection was instead performed by running balanced and pooled samples in a 1% agarose gel and excising the 600 bp to 1200 bp region of interest. The DNA was then purified from the agarose using Promega’s Wizard SV Gel and PCR Clean-Up System. Finally, an Agilent 2100 Bioanalyzer, with a High Sensitivity DNA Kit, was used to quantitate the pooled DNA library before loading onto the MiSeq with other multiplexed samples. Two MiSeq runs were carried out, one with paired-end 250 nt reads on MiSeq V2 chemistry and another with paired-end 300 nt reads on V3 chemistry. The first library was found to have an average insert size of 368 +/- 157 nt, while the second library had inserts with an average size 497 +/- 118 nt.
Assembly and annotation
The genome was assembled using the A5-miseq pipeline, a version of the A5 pipeline that has been revised to process reads up to 500 nt long. Briefly, the A5-miseq pipeline consists of five stages: (1) read quality filtering and error correction, (2) contig assembly, (3) permissive draft scaffolding, (4) misassembly detection, and (5) conservative scaffolding. The revised A5 pipeline uses a new version of idba_ud that uses read pairing information, and that has been modified to accept reads up to 500 nt long and to construct de Bruijn graphs with k-mers up to 500 nt. These modifications provide substantial improvements in assembly contiguity.
The genome was annotated with the RAST annotation system using FigFAM release 70. Putative antibiotic resistance genes and other genes of interest identified by RAST annotation were manually curated using the NCBI ORF finder and iterative BLASTn and BLASTp searches.
The A5 pipeline includes a quality checking step that detects putative misassemblies by identifying clusters of read pairs that map to disjoint locations in the assembled genome. This method did not detect any putative misassemblies.
Comparison of the gene content between E. coli 2009-46 and the finished E. coli 536 reference genome identified 164 annotated gene functions predicted to be present only in E. coli 2009-46. Included among these are several genes related to scavenging iron, a type VII secretion system, an IncF conjugation system, mediators of hyperadherence, and copper and mercury resistance genes. The full list of gene functions found only in 2009-46 and those which 2009-46 lacks relative to the reference isolate are listed in Additional files1 and2, respectively.
The b l aTEM1 gene, conferring resistance to ampicillin, was present on scaffold 78.1 (2551 nt), while the sul2-strA-strB genes conferring resistance to sulphonamides and streptomycin was located on scaffold 67.1, which was 5064 nt long. Ends of both the scaffolds had a partial copy the insertion element IS26. The isolate also houses a clinical class 1 integron and two associated resistance genes on scaffold 71.1. One of the two resistance genes is a variant of dihydrofolate reductase (dhfr) gene which provides trimethoprim resistance to isolates and the other confers resistance to aminoglocoside antibiotics (aadA). However the scaffold, 71.1, is 3,863 nt long and also has a copy of IS26 at both ends. We identified the presence of the 3’-CS of a class 1 integron on scaffold 58.1 (6679 nt long), that had an IS26 on one end and an IS1 element on the other. Presence of IS26 elements at both ends of seven scaffolds has resulted in scaffold breaks around a region of the genome, which most likely harbours a complex resistance locus (CRL), during the assembly of the genome sequence. We were therefore unable to confirm the exact genomic location of the CRL or resistance genes.
The antibiotic resistance profile of E. coli 2009-46 was experimentally determined using the disk diffusion method. This strain was found to be resistant to Ampicillin, Trimethoprim, Sulphafurazole, Tetracycline, Streptomycin, Apramycin, Kanamycin, and Azithromycin. A full list of antibiotics tested and E. coli 2009-46 susceptibility is provided in Additional file3.
To better understand the genomic basis for the observed antibiotic resistance traits, the genome was searched for specific genes known to confer antibiotic resistance. A listing of these genes and their presence or absence in E. coli 2009-46 is provided in Additional file3.
Improved efficiency of clinical genomics pipelines will eventually enable fine-scale epidemiological monitoring of E. coli outbreaks in real time. When fully developed, this capacity will influence clinical and public health decisions related to treatment and control of pathogen outbreaks. Genomic data such as is presented here will aid in the interpretation of data from future outbreaks.
The draft genome assembly has been submitted to NCBI and is associated with BioSample accession SAMN02725027. Genome annotations are available from the RAST web server under accession 562.3620. The Illumina sequence reads have been deposited to the Short Read Archive under accessions SRX514806 and SRX514807. CDS: Coding DNA sequences; ORF: Open Reading frame; RAST: Rapid annotation using subsystem technology; A5: Andrew and Aaron’s Awesome Assembly; gDNA: genomic DNA; nt: Nucleotides;
This work was supported by a collaboration between the NSW Department of Primary Industries and the ithree institute. Strain was donated by the Natalie Miller of the Sydney Adventist Hospital Microbiology laboratory. We thank Fiona MacIver for providing comments on a draft of this manuscript.
- Russo TA, Johnson JR: Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 2003, 5 (5): 449-456. 10.1016/S1286-4579(03)00049-2.View ArticlePubMedGoogle Scholar
- Russo TA, Johnson JR: Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis. 2000, 181 (5): 1753-1754. 10.1086/315418.View ArticlePubMedGoogle Scholar
- Johnson JR, Sannes MR, Croy C, Johnston B, Clabots C, Kuskowski MA, Bender J, Smith KE, Winokur PL, Belongia EA: Antimicrobial drug–resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002–2004. Emerg Infect Dis. 2007, 13 (6): 838-10.3201/eid1306.061576.PubMed CentralView ArticlePubMedGoogle Scholar
- Vincent C, Boerlin P, Daignault D, Dozois CM, Dutil L, Galanakis C, Reid-Smith RJ, Tellier P-P, Tellis PA, Ziebell K, Manges AR: Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis. 2010, 16 (1): 88-10.3201/eid1601.091118.PubMed CentralView ArticlePubMedGoogle Scholar
- Jakobsen L, Garneau P, Bruant G, Harel J, Olsen S, Porsbo LJ, Hammerum A, Frimodt-Møller N: Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat. Eur J Clin Microbiol Infect Dis. 2012, 31 (6): 1121-1129. 10.1007/s10096-011-1417-5.View ArticlePubMedGoogle Scholar
- Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, Upton M: Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother. 2012, 67 (2): 346-356. 10.1093/jac/dkr451.View ArticlePubMedGoogle Scholar
- Kudinha T, Johnson JR, Andrew SD, Kong F, Anderson P, Gilbert GL: Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary escherichia coli isolates from reproductive-age women. J Clin Microbiol. 2013, 51 (10): 3270-3276. 10.1128/JCM.01315-13. doi:10.1128/JCM.01315-13. [http://jcm.asm.org/content/51/10/3270.full.pdf+html]PubMed CentralView ArticlePubMedGoogle Scholar
- Abraham S, Wong HS, Turnidge J, Johnson JR, Trott DJ: Carbapenemase-producing bacteria in companion animals: a public health concern on the horizon. J Antimicrob Chemother. 2014, 69 (5): 1155-1157. 10.1093/jac/dkt518. doi:10.1093/jac/dkt518. [http://jac.oxfordjournals.org/content/69/5/1155.full.pdf+html]View ArticlePubMedGoogle Scholar
- Platell JL, Trott DJ, Johnson JR, Heisig P, Heisig A, Clabots CR, Johnston B, Cobbold RN: Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia. Antimicrob Agents Chemother. 2012, 56 (7): 3898-3904. 10.1128/AAC.06120-11.PubMed CentralView ArticlePubMedGoogle Scholar
- Tritt A, Eisen JA, Facciotti MT, Darling AE: An integrated pipeline for de novo assembly of microbial genomes. PLoS ONE. 2012, 7 (9): 42304-10.1371/journal.pone.0042304. doi:10.1371/journal.pone.0042304.View ArticleGoogle Scholar
- Aziz R, Bartels D, Best A, DeJongh M, Disz T, Edwards R, Formsma K, Gerdes S, Glass E, Kubal M, Meyer F, Olsen G, Olson R, Osterman A, Overbeek R, McNeil L, Paarmann D, Paczian T, Parrello B, Pusch G, Reich C, Stevens R, Vassieva O, Vonstein V, Wilke A, Zagnitko O: The RAST Server: Rapid Annotations using Subsystems Technology. BMC Genomics. 2008, 9 (1): 75-10.1186/1471-2164-9-75. doi:10.1186/1471-2164-9-75.PubMed CentralView ArticlePubMedGoogle Scholar
- Darling AE, Jospin G, Lowe E, Matsen IV FA, Bik HM, Eisen JA: Phylosift: phylogenetic analysis of genomes and metagenomes. PeerJ. 2014, 2: 243.View ArticleGoogle Scholar
- Price MN, Dehal PS, Arkin AP: Fasttree 2–approximately maximum-likelihood trees for large alignments. PloS one. 2010, 5 (3): 9490-10.1371/journal.pone.0009490.View ArticleGoogle Scholar
- Rissman AI, Mau B, Biehl BS, Darling AE, Glasner JD, Perna NT: Reordering contigs of draft genomes using the Mauve aligner. Bioinformatics. 2009, 25 (16): 2071-2073. 10.1093/bioinformatics/btp356.PubMed CentralView ArticlePubMedGoogle Scholar
- Grant JR, Stothard P: The CGView Server: a comparative genomics tool for circular genomes. Nucleic Acids Res. 2008, 36 (suppl 2): 181-184.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.